Literature DB >> 16896592

Prognostic factors and significance of the revised 6th edition of the AJCC classification in patients with locally advanced nasopharyngeal carcinoma.

Anna Kalogera-Fountzila1, Dimitrios Karanikolas, Nikos Katodritis, Epaminodas Samantas, Apostolos Sarafopoulos, Ippoliti Ikonomou, Nikolaos Zamboglou, Nikolaos Tselis, Athanassios-Sokratis Dimitriadis, George Fountzilas.   

Abstract

PURPOSE: To compare the 4th edition 1992 and 6th edition 2002 of the American Joint Committee on Cancer (AJCC) staging systems, to evaluate the paranasopharyngeal structures and lymph node involvement, and to define the prognostic significance of the above factors to overall survival (OS) in patients with locally advanced nasopharyngeal carcinoma (NPC). PATIENTS AND METHODS: CT images of 162 patients, who were diagnosed with NPC and received irradiation alone or chemotherapy and irradiation, were retrospectively reviewed. CT scans, performed prior to and after the completion of treatment, were reviewed.
RESULTS: The parapharyngeal space was found to be involved very commonly (98%). 50 of 162 patients (31%) displayed parapharyngeal extension of the tumor to degree A, 59 patients (36%) showed degree B, and 50 patients (31%) degree C nasopharyngeal extension. According to the AJCC 6th edition 2002, patients were distributed into stages IIA, IIB, III, IVA, and IVB. By contrast, using the AJCC 4th edition 1992, patients were distributed into stages III and IV only. After a median follow up of 71.1 months, median survival was 60.7 months, with a 2-year survival rate of 71.3% and a 3-year survival rate of 62.2%. Multivariate analysis identified age, degree of parapharyngeal lateral extension, cavernous-sinus-infiltration, and size of infiltrated lymph nodes as independent prognostic factors for OS.
CONCLUSION: The 6th revision of TNM staging reported herein, provides a more uniform distribution of patients between stages. The degree of tumor extension into the parapharyngeal space should be considered in future TNM staging revisions.

Entities:  

Mesh:

Year:  2006        PMID: 16896592     DOI: 10.1007/s00066-006-1538-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  5 in total

1.  Simultaneous integrated boost intensity-modulated radiotherapy (SIB‑IMRT) in nasopharyngeal cancer.

Authors:  Evangelia Peponi; Christoph Glanzmann; Guntram Kunz; Christoph Renner; Katja Tomuschat; Gabriela Studer
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

2.  A comparison between the sixth and seventh editions of the UICC/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort.

Authors:  Jing Li; Xiong Zou; Yun-Long Wu; Jing-Cui Guo; Jing-Ping Yun; Miao Xu; Qi-Sheng Feng; Li-Zhen Chen; Jin-Xin Bei; Yi-Xin Zeng; Ming-Yuan Chen
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

3.  Correlation of the AKT/mTOR signaling pathway with the clinicopathological features and prognosis of nasopharyngeal carcinoma.

Authors:  Yan Wang; Jie Sun; Ninghua Yao
Journal:  Eur J Histochem       Date:  2021-11-16       Impact factor: 3.188

4.  Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma.

Authors:  Li Yin; Xiu-Hua Bian; Xue Wang; Meng Chen; Jing Wu; Jian-Hua Xu; Pu-Dong Qian; Wen-Jie Guo; Xue-Song Jiang; Huan-Feng Zhu; Jia-Jia Gu; Jian-Feng Wu; Ye-wei Zhang; Xia He
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

5.  LOX expression in primary nasopharyngeal carcinoma: correlation with prognostic parameters and outcome.

Authors:  Yi-Jun Hua; Hai-Yun Wang; Ling-Quan Tang; Qiu-Yan Chen; Jian-Yong Shao; Hai-Qiang Mai
Journal:  Oncotarget       Date:  2016-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.